2026-06-06T01:27:54Zhttps://ora4-rhel9-prd-public1.bodleian.ox.ac.uk/oai2oai:ora.ox.ac.uk:uuid:48808857-bd28-4422-8395-f9bff73d8b812026-05-20T10:34:37Ztype_of_work:journal_article
http://creativecommons.org/licenses/by-nc/4.0/
application/pdf
https://ora.ox.ac.uk/objects/uuid:48808857-bd28-4422-8395-f9bff73d8b81/files/m5f820fe3e8d368c0903e24ca5ec8c47b
eng
Springer
https://ora.ox.ac.uk/objects/uuid:48808857-bd28-4422-8395-f9bff73d8b81/files/m5f820fe3e8d368c0903e24ca5ec8c47b
0741-238X
Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma
2018-04-26
Busse, WW
Maspero, JF
Rabe, KF
Papi, A
Wenzel, SE
Ford, LB
Pavord, Ian D.
Zhang, B
Staudinger, H
Pirozzi, G
Amin, N
Akinlade, B
Eckert, L
Chao, J
Graham, NMH
Teper, A
2018-05-03
Journal Article/Review
VoR
https://dx.doi.org/10.1007/s12325-018-0702-4